Drug intelligence / Profile preview

Sang-Qi Granula

Development stage
Unknown
Lead developer
China-Japan Friendship Hospital
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sang-Qi Granula (also known as Sangqi Qingxuan formula) is a traditional Chinese medicine (TCM) herbal granule formulation developed by the China-Japan Friendship Hospital for the treatment of primary hypertension and associated vascular endothelial dysfunction. The formula is composed of eight medicinal herbs: Herba Taxilli, Fructus Lycii, Cortex Eucommiae, Semen Cassiae, Radix et Rhizoma Salviae Miltiorrhizae, Rhizoma Alismatis, Radix Puerariae Lobatae, and Flos Chrysanthemi indici. Sang-Qi Granula exerts its antihypertensive and cardioprotective effects by improving vascular endothelial function, reducing blood pressure, and preventing myocardial fibrosis. Mechanistically, it has been shown to suppress inflammatory responses by downregulating NF-κB and TGF-β signaling pathways while upregulating peroxisome proliferator-activated receptors alpha and gamma (PPARα and PPARγ).

Other names
SQSQGSQQXSang-Qi granulesSang-qi GranulaSangqi GranulaSangqi GranulesSangqi Qingxuan formulaSangqi Qingxuan granuleSangqi Qingxuan granules
02

Targets

NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)SMAD3 (SMAD family member 3)

Beyond the preview

Go deeper on Sang-Qi Granula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sang-Qi Granula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call